Today, the Company presented results from a Phase 2b dose-ranging and proof of concept study of elismetrep, a novel TRPM8 channel blocker and the only agent known to be in late-stage development for ...

Migraine prevention improved at 3 months in a real world study comparing galcanezumab with oral therapies. Read more.

Add Yahoo as a preferred source to see more of our stories on Google. Migraine sufferers may benefit from new therapies that address prevention. Marion Groening/SZ ...

VYEPTI is indicated for the preventive treatment of migraine in adults. VYEPTI is contraindicated in patients with serious hypersensitivity to eptinezumab-jjmr or to any of its ingredients. Reactions ...

The American College of Physicians (ACP) supports meaningful, evidence-based performance measures for internal medicine that ...

Neuroscientists have recently made some important discoveries about what causes migraines, including that migraine sufferers have higher levels of CGRP, a protein in the brain and nervous system ...

Add Yahoo as a preferred source to see more of our stories on Google. For Cherise Irons, chocolate, red wine and aged cheeses are dangerous. So are certain sounds, perfumes and other strong scents, ...

Migraines can feel overwhelming, but understanding your triggers, building healthy habits, and exploring treatment options can make a real difference. From sleep routines to supplements, there are ...

Chronic migraine can greatly affect your life, especially when the pain arrives suddenly and traditional medications don't seem to help. An alternative remedy currently being studied may offer help ...

There are 2 goals to migraine therapy: shortening or stopping an acute attack, and preventing future attacks to decrease migraine frequency and possible severity. 7,16 Because migraine attacks are ...

SAN DIEGO, California — Nearly one in three patients with migraine is reluctant to seek medical help and many blame health care providers, results of a recent survey showed. Participants cited ...

H. Lundbeck A/S (Lundbeck) today presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology (AAN) 2026 Annual Meeting, underscoring the importance of ...